Document Classification

Section Type: RESULTS

Text: E2 1 mg/NGM 90 microg was associated with significant (ie, the 95 % CI did not include 0) increases in high-density lipoprotein cholesterol (HDL-C) (6. 8 % [95 % CI = 4. 7 %, 9. 0 %] and 4. 8 % [2. 3 %, 7. 2 %] at months 7 and 12, respectively) and high-density lipoprotein 2 cholesterol (HDL2-C) (10. 8 % [6. 2 %, 15. 3 %] and 24. 1 % [18. 9 %, 29. 4 %]) concentrations, and decreases in total cholesterol (-7. 7 % [-9. 0 %, -6. 3 %] and -9. 2 % [-10. 5 %, -7. 9 %]), low-density lipoprotein cholesterol (-14. 3 % [-16. 3 %, -12. 4 %] and -14. 9 % [-16. 7 %, -13. 2 %]), and lipoprotein (a) (-30. 6 % [-41. 4 %, -20. 0 %] at month 12) concentrations.